img

Global Acquired hemophilia A Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Acquired hemophilia A Treatment Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application

ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer.
Acquired hemophilia A Treatment report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Acquired hemophilia A Treatment market is projected to reach US$ 996.1 million in 2029, increasing from US$ 1245 million in 2022, with the CAGR of -3.2% during the period of 2024 to 2029. Demand from Hospital and Pharmacy are the major drivers for the industry.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acquired hemophilia A Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Sanofi
Sobi
Segment by Type
200IU
250IU

Segment by Application


Hospital
Pharmacy
By Region
North America
the United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Acquired hemophilia A Treatment market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2024, 2024-2029).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Acquired hemophilia A Treatment introduction, etc. Acquired hemophilia A Treatment Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Acquired hemophilia A Treatment market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Acquired hemophilia A Treatment
1.1 Acquired hemophilia A Treatment Market Overview
1.1.1 Acquired hemophilia A Treatment Product Scope
1.1.2 Acquired hemophilia A Treatment Market Status and Outlook
1.2 Global Acquired hemophilia A Treatment Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Acquired hemophilia A Treatment Market Size by Region (2018-2029)
1.4 Global Acquired hemophilia A Treatment Historic Market Size by Region (2018-2024)
1.5 Global Acquired hemophilia A Treatment Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Acquired hemophilia A Treatment Market Size (2018-2029)
1.6.1 North America Acquired hemophilia A Treatment Market Size (2018-2029)
1.6.2 Europe Acquired hemophilia A Treatment Market Size (2018-2029)
1.6.3 Asia-Pacific Acquired hemophilia A Treatment Market Size (2018-2029)
1.6.4 Latin America Acquired hemophilia A Treatment Market Size (2018-2029)
1.6.5 Middle East & Africa Acquired hemophilia A Treatment Market Size (2018-2029)
2 Acquired hemophilia A Treatment Market by Type
2.1 Introduction
2.1.1 200IU
2.1.2 250IU
2.2 Global Acquired hemophilia A Treatment Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Acquired hemophilia A Treatment Historic Market Size by Type (2018-2024)
2.2.2 Global Acquired hemophilia A Treatment Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Acquired hemophilia A Treatment Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Acquired hemophilia A Treatment Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Acquired hemophilia A Treatment Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Acquired hemophilia A Treatment Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Acquired hemophilia A Treatment Revenue Breakdown by Type (2018-2029)
3 Acquired hemophilia A Treatment Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Pharmacy
3.2 Global Acquired hemophilia A Treatment Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Acquired hemophilia A Treatment Historic Market Size by Application (2018-2024)
3.2.2 Global Acquired hemophilia A Treatment Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Acquired hemophilia A Treatment Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Acquired hemophilia A Treatment Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Acquired hemophilia A Treatment Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Acquired hemophilia A Treatment Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Acquired hemophilia A Treatment Revenue Breakdown by Application (2018-2029)
4 Acquired hemophilia A Treatment Competition Analysis by Players
4.1 Global Acquired hemophilia A Treatment Market Size by Players (2018-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acquired hemophilia A Treatment as of 2022)
4.3 Date of Key Players Enter into Acquired hemophilia A Treatment Market
4.4 Global Top Players Acquired hemophilia A Treatment Headquarters and Area Served
4.5 Key Players Acquired hemophilia A Treatment Product Solution and Service
4.6 Competitive Status
4.6.1 Acquired hemophilia A Treatment Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Sanofi
5.1.1 Sanofi Profile
5.1.2 Sanofi Main Business
5.1.3 Sanofi Acquired hemophilia A Treatment Products, Services and Solutions
5.1.4 Sanofi Acquired hemophilia A Treatment Revenue (US$ Million) & (2018-2024)
5.1.5 Sanofi Recent Developments
5.2 Sobi
5.2.1 Sobi Profile
5.2.2 Sobi Main Business
5.2.3 Sobi Acquired hemophilia A Treatment Products, Services and Solutions
5.2.4 Sobi Acquired hemophilia A Treatment Revenue (US$ Million) & (2018-2024)
5.2.5 Sobi Recent Developments
6 North America
6.1 North America Acquired hemophilia A Treatment Market Size by Country (2018-2029)
6.2 the United States
6.3 Canada
7 Europe
7.1 Europe Acquired hemophilia A Treatment Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Acquired hemophilia A Treatment Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Acquired hemophilia A Treatment Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Acquired hemophilia A Treatment Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Acquired hemophilia A Treatment Market Dynamics
11.1 Acquired hemophilia A Treatment Industry Trends
11.2 Acquired hemophilia A Treatment Market Drivers
11.3 Acquired hemophilia A Treatment Market Challenges
11.4 Acquired hemophilia A Treatment Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Acquired hemophilia A Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029
Table 2. Global Acquired hemophilia A Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 3. Global Acquired hemophilia A Treatment Market Size Share by Region (2018-2024)
Table 4. Global Acquired hemophilia A Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 5. Global Acquired hemophilia A Treatment Forecasted Market Size Share by Region (2024-2029)
Table 6. Global Acquired hemophilia A Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029
Table 7. Global Acquired hemophilia A Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 8. Global Acquired hemophilia A Treatment Revenue Market Share by Type (2018-2024)
Table 9. Global Acquired hemophilia A Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 10. Global Acquired hemophilia A Treatment Revenue Market Share by Type (2024-2029)
Table 11. North America Acquired hemophilia A Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 12. North America Acquired hemophilia A Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 13. Europe Acquired hemophilia A Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 14. Europe Acquired hemophilia A Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 15. Asia-Pacific Acquired hemophilia A Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 16. Asia-Pacific Acquired hemophilia A Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 17. Latin America Acquired hemophilia A Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 18. Latin America Acquired hemophilia A Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 19. Middle East and Africa Acquired hemophilia A Treatment Revenue by Type (2018-2024) & (US$ Million)
Table 20. Middle East and Africa Acquired hemophilia A Treatment Revenue by Type (2024-2029) & (US$ Million)
Table 21. Global Acquired hemophilia A Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029
Table 22. Global Acquired hemophilia A Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 23. Global Acquired hemophilia A Treatment Revenue Market Share by Application (2018-2024)
Table 24. Global Acquired hemophilia A Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 25. Global Acquired hemophilia A Treatment Revenue Market Share by Application (2024-2029)
Table 26. North America Acquired hemophilia A Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 27. North America Acquired hemophilia A Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 28. Europe Acquired hemophilia A Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 29. Europe Acquired hemophilia A Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 30. Asia-Pacific Acquired hemophilia A Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 31. Asia-Pacific Acquired hemophilia A Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 32. Latin America Acquired hemophilia A Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 33. Latin America Acquired hemophilia A Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 34. Middle East and Africa Acquired hemophilia A Treatment Revenue by Application (2018-2024) & (US$ Million)
Table 35. Middle East and Africa Acquired hemophilia A Treatment Revenue by Application (2024-2029) & (US$ Million)
Table 36. Global Acquired hemophilia A Treatment Revenue (US$ Million) by Players (2018-2024)
Table 37. Global Acquired hemophilia A Treatment Revenue Market Share by Players (2018-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acquired hemophilia A Treatment as of 2022)
Table 39. Date of Key Players Enter into Acquired hemophilia A Treatment Market
Table 40. Global Acquired hemophilia A Treatment Key Players Headquarters and Area Served
Table 41. Acquired hemophilia A Treatment Product Solution and Service
Table 42. Global Acquired hemophilia A Treatment Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Sanofi Basic Information List
Table 45. Sanofi Description and Business Overview
Table 46. Sanofi Acquired hemophilia A Treatment Products, Services and Solutions
Table 47. Revenue (US$ Million) in Acquired hemophilia A Treatment Business of Sanofi (2018-2024)
Table 48. Sanofi Recent Developments
Table 49. Sobi Basic Information List
Table 50. Sobi Description and Business Overview
Table 51. Sobi Acquired hemophilia A Treatment Products, Services and Solutions
Table 52. Revenue (US$ Million) in Acquired hemophilia A Treatment Business of Sobi (2018-2024)
Table 53. Sobi Recent Developments
Table 54. North America Acquired hemophilia A Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 55. North America Acquired hemophilia A Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 56. Europe Acquired hemophilia A Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 57. Europe Acquired hemophilia A Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 58. Asia-Pacific Acquired hemophilia A Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia-Pacific Acquired hemophilia A Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 60. Asia-Pacific Acquired hemophilia A Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 61. Asia-Pacific Acquired hemophilia A Treatment Market Share by Region (2018-2024)
Table 62. Asia-Pacific Acquired hemophilia A Treatment Market Share by Region (2024-2029)
Table 63. Latin America Acquired hemophilia A Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 64. Latin America Acquired hemophilia A Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 65. Latin America Acquired hemophilia A Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 66. Middle East & Africa Acquired hemophilia A Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 67. Middle East & Africa Acquired hemophilia A Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 68. Middle East & Africa Acquired hemophilia A Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 69. Acquired hemophilia A Treatment Market Trends
Table 70. Acquired hemophilia A Treatment Market Drivers
Table 71. Acquired hemophilia A Treatment Market Challenges
Table 72. Acquired hemophilia A Treatment Market Restraints
Table 73. Research Programs/Design for This Report
Table 74. Key Data Information from Secondary Sources
Table 75. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acquired hemophilia A Treatment Market Size Year-over-Year 2018-2029 & (US$ Million)
Figure 2. Global Acquired hemophilia A Treatment Market Size (US$ Million), 2018 VS 2022 VS 2029
Figure 3. Global Acquired hemophilia A Treatment Market Share by Regions: 2022 VS 2029
Figure 4. Global Acquired hemophilia A Treatment Forecasted Market Size Share by Region (2024-2029)
Figure 5. North America Acquired hemophilia A Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 6. Europe Acquired hemophilia A Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 7. Asia-Pacific Acquired hemophilia A Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 8. Latin America Acquired hemophilia A Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 9. Middle East & Africa Acquired hemophilia A Treatment Market Size Growth Rate (2018-2029) & (US$ Million)
Figure 10. Product Picture of 200IU
Figure 11. Global 200IU Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 12. Product Picture of 250IU
Figure 13. Global 250IU Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 14. Global Acquired hemophilia A Treatment Market Size Share by Type: 2022 & 2029
Figure 15. North America Acquired hemophilia A Treatment Revenue Market Share by Type (2018-2029)
Figure 16. Europe Acquired hemophilia A Treatment Revenue Market Share by Type (2018-2029)
Figure 17. Asia-Pacific Acquired hemophilia A Treatment Revenue Market Share by Type (2018-2029)
Figure 18. Latin America Acquired hemophilia A Treatment Revenue Market Share by Type (2018-2029)
Figure 19. Middle East and Africa Acquired hemophilia A Treatment Revenue Market Share by Type (2018-2029)
Figure 20. Hospital Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 21. Pharmacy Market Size (US$ Million) & YoY Growth (2018-2029)
Figure 22. Global Acquired hemophilia A Treatment Market Size Share by Application: 2022 & 2029
Figure 23. North America Acquired hemophilia A Treatment Revenue Market Share by Application (2018-2029)
Figure 24. Europe Acquired hemophilia A Treatment Revenue Market Share by Application (2018-2029)
Figure 25. Asia-Pacific Acquired hemophilia A Treatment Revenue Market Share by Application (2018-2029)
Figure 26. Latin America Acquired hemophilia A Treatment Revenue Market Share by Application (2018-2029)
Figure 27. Middle East and Africa Acquired hemophilia A Treatment Revenue Market Share by Application (2018-2029)
Figure 28. Acquired hemophilia A Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 29. Global Top 5 and Top 10 Players Acquired hemophilia A Treatment Market Share in 2022
Figure 30. North America Acquired hemophilia A Treatment Market Share by Country (2018-2029)
Figure 31. the United States Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 32. Canada Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 33. Germany Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 34. France Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 35. U.K. Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 36. Italy Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 37. Russia Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 38. Nordic Countries Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 39. Asia-Pacific Acquired hemophilia A Treatment Market Share by Region (2018-2029)
Figure 40. China Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 41. Japan Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 42. South Korea Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 44. India Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 45. Australia Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 46. Latin America Acquired hemophilia A Treatment Market Share by Country (2018-2029)
Figure 47. Mexico Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 48. Brazil Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Acquired hemophilia A Treatment Market Share by Country (2018-2029)
Figure 50. Turkey Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 51. Saudi Arabia Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 52. UAE Acquired hemophilia A Treatment Market Size (2018-2029) & (US$ Million)
Figure 53. Bottom-up and Top-down Approaches for This Report

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries